Utama › Kanser (semua jenis) › California › Los Angeles
Kajian klinikal Kanser (semua jenis) di Los Angeles, CA
74 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Mengambil pesertaFasa 3
- Keck Medicine of USC, Los Angeles
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2/3
- USC Norris Comprehensive Cancer Center /ID# 275343, Los Angeles
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Mengambil pesertaFasa 2
- Start Los Angeles /ID# 281533, Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, Los Angeles
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Mengambil pesertaFasa 1/2
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Mengambil pesertaFasa 3
- The Angeles Clinic and Research Institute, West Los Angeles Office, Los Angeles
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 7, Los Angeles
Intratumoral N17350 in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Mengambil pesertaFasa 1/2
- Childrens Hospital Los Angeles ( Site 3006), Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
- UCLA Medical Center, Los Angeles
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Mengambil pesertaFasa 1/2
- University of Southern California /ID# 272414, Los Angeles
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Mengambil pesertaFasa 1/2
- University of Southern California Norris Comprehensive, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Mengambil pesertaFasa 1/2
- California Research Institute, Los Angeles
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Cedars-Sinai Medical Center, Los Angeles
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaKajian pemerhatian
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- Los Angeles Cancer Network, Los Angeles
- Cedars-Sinai Cancer at Cedars-Sinai Medical Facility, Los Angeles
- Los Angeles Cancer Network_Century City, Los Angeles
- dan 3 lagi
Lurbinectedin in FET-Fused Tumors
Mengambil pesertaFasa 1/2
- Cedars-Sinai Medical Center, Los Angeles
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of California, Los Angeles (Data or Specimen Analysis Only), Los Angeles
A Study of ARC-02 in B-cell NHL
Mengambil pesertaFasa 1
- Start Cala, Los Angeles
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Mengambil pesertaFasa 1
- UCLA, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Effect of Meal Timing During Adjuvant Treatment for Cancer
Mengambil peserta
- Cedars Sinai Medical Center (CSMC), Los Angeles
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Children's Hospital Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Mattel Children's Hospital UCLA, Los Angeles
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Mengambil pesertaFasa 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California Los Angeles, Los Angeles
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Site 03, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- University of California, Los Angeles (UCLA), Los Angeles
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Mengambil peserta
- Cedars-Sinai Medical Center, Los Angeles
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- START Los Angeles, Los Angeles
International Rare Brain Tumor Registry
Mengambil pesertaKajian pemerhatian
- Children's Hospital Los Angeles, Los Angeles
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Mengambil pesertaFasa 2
- UCLA Medical Center, Los Angeles
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Kaiser Permanente West Los Angeles, Los Angeles
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
Mengambil pesertaFasa 2
- Cedars Sinai Medical Center, Los Angeles
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Mengambil pesertaFasa 2
- Children's Hospital Los Angeles, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Mengambil pesertaFasa 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Children's Hospital Los Angeles, Los Angeles
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Mengambil pesertaFasa 2
- USC Norris Comprehensive Cancer Center /ID# 274550, Los Angeles
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Ellison Clinic at Saint John's, Los Angeles
The STOP-MED CTRCD Trial
Mengambil pesertaFasa 4
- University of California, Los Angeles, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
- UCLA Department of Medicine, Los Angeles
EXoPERT EMERALD Clinical Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- City of Hope Duarte Cancer Center, Los Angeles
Molecular Genetics Studies of Cancer Patients and Their Relatives
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Mengambil pesertaFasa 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Children's Hospital Los Angeles, Los Angeles
- University of California-Los Angeles, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- UCLA Medical Center, Los Angeles
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Mengambil pesertaFasa 1/2
- The Angeles Clinic and Research Institute, Los Angeles
LIFE Cancer Survivorship Database for Pediatric Cancer
Mengambil pesertaKajian pemerhatian
- Children's Hospital Los Angeles, Los Angeles
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
Mengambil pesertaSukarelawan sihat dialu-alukan
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- University of Southern California, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Mengambil peserta
- Oncology Institute for Hope and Innovation, Los Angeles
Norris ORIEN Total Cancer Care
Mengambil pesertaKajian pemerhatian
- USC / Norris Comprehensive Cancer Center, Los Angeles
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
Mengambil pesertaFasa 1/2
- Los Angeles General Medical Center, Los Angeles
- USC/Norris Comprehensive Cancer Center, Los Angeles
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- UCLA, Los Angeles
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Jonsson Comprehensive Cancer Center, Los Angeles
eMOTION: Examining Implicit Attitudes in Physical Activity Engagement
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Univeristy of Southern California, Los Angeles
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Mengambil pesertaFasa 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- UCLA Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- University of Southern California, Los Angeles
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Mengambil peserta
- Cedars-Sinai Medical Center (CSMC), Los Angeles
- University of California Los Angeles, Los Angeles
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
Mengambil pesertaSukarelawan sihat dialu-alukan
- Children's Hospital Los Angeles, Los Angeles
eMOTION: Examining Affective Mechanisms in Physical Activity Engagement
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of Southern California, Los Angeles
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Mengambil pesertaKajian pemerhatian
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- UCLA Health, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Mengambil pesertaFasa 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Trial of DFP-14927 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- UCLA Department of Medicine- Hematology/Oncology, Los Angeles
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Mengambil pesertaFasa 1/2
- The Angeles Clinic and Research Institute, Los Angeles
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- MiraKind, Los Angeles
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- Los Angeles General Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- dan 2 lagi
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Mengambil pesertaFasa 4
- VA Greater Los Angeles Healthcare System, Los Angeles
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY109 kajian
- Boston, MA85 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Washington, DC58 kajian
- Durham, NC58 kajian
- Chicago, IL51 kajian
- Atlanta, GA49 kajian
- Seattle, WA49 kajian
- Arlington, VA48 kajian
- St. Louis, MO46 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser Payudara73 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
- Kanser Payudara Triple-Negatif27 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.